LYNCHNOW® delivers timely and cost-efficient results.
The protocol, which is largely accepted throughout the medical field, consists of first screening for DNA mismatch repair (MMR) proteins MLH1, MSH2, MSH6, and PMS2 by way of immunohistochemistry.
This process gives results in 3-5 days and allows the clinician to make a rapid decision on the next step.